Aclaris Therapeutics

Aclaris Therapeutics

ACRS· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +21.4% in FY2025

Neal Walker is the CEO of Aclaris Therapeutics and was paid $3.4M in FY2025 (Dec), up 134%.

Pay$100 in the stock at the end of FY23 → $287
CEO pay is from each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Neal WalkerFY2025
  2. 2James LoeropFY2023
  3. 3Kevin BalthaserFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Aclaris Therapeutics paid CEO Neal Walker $3.4M in FY2025 (Dec). No other named executive of that year is on file.

Name
Neal WalkerChief Executive OfficerNot disclosed
James LoeropChief Business OfficerNot disclosedNot disclosed
Kevin BalthaserChief Financial OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers24

See all

The FY2023 (Dec) proxy of Aclaris Therapeutics names 24 peer companies for pay. Among Aclaris Therapeutics and these peers, CEO pay was 5th highest of 10 and total shareholder return was 8th highest of 10.

5th highest of 10in Aclaris Therapeutics and its pay peers, FY2023 (Dec) by CEO pay:

$3.5M$9.7M

8th highest of 10in Aclaris Therapeutics and its pay peers, FY2023 (Dec) by total shareholder return:

$22$1,778

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Anand MehraDirector · 11 yr on the boardIndependentCompensation (Chair)—Paid as an executive
  • William HumphriesDirector · 9 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
  • Maxine GowenDirector · 6 yr on the boardIndependentAudit—Paid as an executive
  • Vincent MilanoDirector · 5 yr on the boardIndependentAudit (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 24, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 25, 2024FY2023
Annual report10-KFeb 27, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data